Burning Rock Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Kynam Capital Management, LP(8.4%),Kynam Capital Management GP, LLC(8.4%), etc.
燃石醫學 | SC 13G:超過5%持股股東披露文件-Kynam Capital Management, LP(8.4%),Kynam Capital Management GP, LLC(8.4%)等
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。